Amparo Alvarez-Valdés

Amparo Alvarez-Valdés

Auto-generated profile, based on publicly available information

Amparo Alvarez-Valdés

Universidad Autónoma de Madrid

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2012 in Inorganic Chemistry
Verified
Journal Article
Closed access
Luigi MessoriLuigi Messori
Luigi Messori
LCLeticia Cubo
Leticia Cubo
Chiara GabbianiChiara Gabbiani
Chiara Gabbiani
AÁAmparo Álvarez-Valdés
Amparo Álvarez-Valdés
EMElena Michelucci
Elena Michelucci
AQAdoracion Gomez Quiroga
Adoracion Gomez Quiroga

25 January 2017 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
LQLetícia Quental
Letícia Quental
PRPaula Dolores Raposinho
Paula Dolores Raposinho
Filipa MendesFilipa Mendes
Filipa Mendes
ISIsabel Santos
Isabel Santos
CNCarmen Navarro-Ranninger
Carmen Navarro-Ranninger
António PauloAntónio Paulo
António Paulo
In this article, we report on the development of new metal-based anticancer agents with imaging, chemotherapeutic and photosensitizing properties. Hence, a new heterobimetallic complex (Pt-LQ-Re) was prepared by connecting a non-conventional trans-chlorido Pt(II) complex to a photoactive Re tricarbonyl unit (LQ-Re), which can be replaced by 99mTc to allow for in vivo imaging. We describe the photophysical and biological properties of the new complexes, in the dark and upon light irradiation (DNA interaction, cellular localization and uptake, and cytotoxicity). Furthermore, planar scintigraphic images of mice injected with Pt-LQ-Tc clearly showed that the radioactive compound is taken up by the excretory system organs, namely liver and kidneys, without significant retention in other tissues. All in all, the strategy of conjugating a chemotherapeutic compound with a PDT photosensitizer endows the resulting complexes with an intrinsic cytotoxic activity in the dark, driven by the non-classical platinum core, and a selective activity upon light irradiation. Most importantly, the possibility of integrating a SPECT imaging radiometal (99mTc) in the structure of these new heterobimetallic complexes might allow for in vivo non-invasive visualization of their tumoral accumulation, a crucial issue to predict therapeutic outcomes.

20 March 2002 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
AAAmparo Alvarez-Valdés
Amparo Alvarez-Valdés
JPJosé Manuel Pérez
José Manuel Pérez
ILIsabel López-Solera
Isabel López-Solera
RLRaúl Lannegrand
Raúl Lannegrand
JCJosé Manuel Continente
José Manuel Continente
CNCarmen Navarro-Ranninger
Carmen Navarro-Ranninger

1 October 1999 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
JPJ.M. Pérez
J.M. Pérez
EME.I. Montero
E.I. Montero
AGA.M. González
A.M. González
AAA. Alvarez-Valdés
A. Alvarez-Valdés
CAC. Alonso
C. Alonso
CNC. Navarro-Ranninger
C. Navarro-Ranninger

30 June 2011 in MedChemComm
Verified
Journal Article
Closed access
PDF file
José AlemánJosé Alemán
José Alemán
VFVirginia del Solar Fernandez
Virginia del Solar Fernandez
AAAmparo Alvarez-Valdés
Amparo Alvarez-Valdés
CRCarla Ríos-Luci
Carla Ríos-Luci
Jose M. PadronJose M. Padron
Jose M. Padron
CNCarmen Navarro-Ranninger
Carmen Navarro-Ranninger
In this work, we described for the first time the synthesis of trans-N-sulfonamide platinum complexes. The antiproliferative activity (GI50, μM) of these new compounds in human solid tumors cells was compared to cisplatin.

1 June 2011 in Polyhedron
Verified
Journal Article
Closed access
AQAdoracion Gomez Quiroga
Adoracion Gomez Quiroga
FRF.J. Ramos-Lima
F.J. Ramos-Lima
AAA. Alvarez-Valdés
A. Alvarez-Valdés
MFM. Font-Bardía
M. Font-Bardía
ABAlberta Bergamo
Alberta Bergamo
CNC. Navarro-Ranninger
C. Navarro-Ranninger